In summary, the splicing factor YB1 is highly expressed in osteosarcoma cells and promotes the proliferation, metastasis, angiogenesis, and inhibition of apoptosis of osteosarcoma cells through its influence on downstream pathways. Here, SLU7 is linked to osteosarcoma.